Comment on ‘‘how does omalizumab affect the immunoinflammatory response in patients with chronic spontaneous urticaria?’’: reply from author
Cutaneous and Ocular Toxicology, cilt.39, sa.1, ss.73, 2020 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Teknik Not
- Cilt numarası: 39 Sayı: 1
- Basım Tarihi: 2020
- Doi Numarası: 10.1080/15569527.2019.1710181
- Dergi Adı: Cutaneous and Ocular Toxicology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, Environment Index, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.73
- Anahtar Kelimeler: Neutrophil to monocyte ratio, inflammation, neutrophil to lymphocyte ratio
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
We read Cosansu's commentary entitled ‘’Hematological parameters in patients with chronic spontaneous urticaria’’ to our study with a great interest. The author noted that monocytes increased in inflammatory diseases such as urticaria but decreased after treatment. She argued that NMR was not used as an inflammatory marker in previous studies, so that NMR should not be used to evaluate the response to omalizumab treatment in urticaria and decreased by chance. We thank the author for her interest in our article.